Warfarin for Atrial Fibrillation in Patients With End-Stage Renal Disease: The Problem of Observational Studies
Chest
.
2016 Oct;150(4):981.
doi: 10.1016/j.chest.2016.07.021.
Authors
Christiaan Lucas Meuwese
1
,
Judith Kooiman
2
,
Merel van Diepen
3
,
Juan Jesus Carrero
4
Affiliations
1
Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address:
[email protected]
.
2
Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
3
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
4
Department of Renal Medicine, CLINTEC, Karolinska Institutet, Stockholm, Sweden.
PMID:
27719817
DOI:
10.1016/j.chest.2016.07.021
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants
Atrial Fibrillation*
Humans
Kidney Failure, Chronic
Stroke
Warfarin*
Substances
Anticoagulants
Warfarin